These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 20394542)
41. Conjunctival and corneal sensitivity in patients under topical antiglaucoma treatment. Romero-Díaz de León L; Morales-León JE; Ledesma-Gil J; Navas A Int Ophthalmol; 2016 Jun; 36(3):299-303. PubMed ID: 26272426 [TBL] [Abstract][Full Text] [Related]
42. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication. Ghosh S; O'Hare F; Lamoureux E; Vajpayee RB; Crowston JG Clin Exp Ophthalmol; 2012; 40(7):675-81. PubMed ID: 22394358 [TBL] [Abstract][Full Text] [Related]
43. Reliability of fluorescein dye disappearance test in assessment of adults with nasolacrimal duct obstruction. Kashkouli MB; Mirzajani H; Jamshidian-Tehrani M; Pakdel F; Nojomi M; Aghaei GH Ophthalmic Plast Reconstr Surg; 2013; 29(3):167-9. PubMed ID: 23503058 [TBL] [Abstract][Full Text] [Related]
44. Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications. Kim JH; Shin YU; Seong M; Cho HY; Kang MH Cornea; 2018 Apr; 37(4):421-425. PubMed ID: 29227342 [TBL] [Abstract][Full Text] [Related]
45. The effects of nasolacrimal canal blockage on topical medications for glaucoma. Aritürk N; Oge I; Erkan D; Süllü Y; Sahin M Acta Ophthalmol Scand; 1996 Aug; 74(4):411-3. PubMed ID: 8883562 [TBL] [Abstract][Full Text] [Related]
46. Adherence to topical glaucoma medication during hospitalization. Yousuf SJ; Jones LS J Glaucoma; 2011 Dec; 20(9):573-6. PubMed ID: 21048511 [TBL] [Abstract][Full Text] [Related]
47. Acquired external punctal stenosis: etiology and associated findings. Kashkouli MB; Beigi B; Murthy R; Astbury N Am J Ophthalmol; 2003 Dec; 136(6):1079-84. PubMed ID: 14644218 [TBL] [Abstract][Full Text] [Related]
53. Punctal occlusion and topical medications for glaucoma. Huang TC; Lee DA Am J Ophthalmol; 1989 Feb; 107(2):151-5. PubMed ID: 2913809 [TBL] [Abstract][Full Text] [Related]
54. Obstruction of lacrimal sac caused by topical epinephrine. Barishak R; Romano A; Stein R Ophthalmologica; 1969; 159(4):373-9. PubMed ID: 4986711 [No Abstract] [Full Text] [Related]
55. Anti-glaucoma medication exposure in pregnancy: an observational study and literature review. Razeghinejad MR; Nowroozzadeh MH Clin Exp Optom; 2010 Nov; 93(6):458-65. PubMed ID: 21182661 [TBL] [Abstract][Full Text] [Related]
56. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies. Flach AJ Trans Am Ophthalmol Soc; 2008; 106():138-45; discussion 145-8. PubMed ID: 19277229 [TBL] [Abstract][Full Text] [Related]